Search Main Menu Main Content
  • Change contrast :
Haute Autorité de Santé
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

1 result

  • Topics : Economics and public health
  • Topics : Paediatrics
  • Topics : Pregnancy and reproduction
  • Topics : Bacterial infections
  • Language : Français
  • Active substance : spectinomycine
  • Active substance : ceftriaxone
Filter
Topic
  • Economics and public health (1)
  • Plus ...
    • Screening, prevention (1)
  • Diseases and conditions (1)
  • Plus ...
    • Infectious diseases (1)
    • Plus ...
      • Bacterial infections (1)
    • Pregnancy and reproduction (1)
    • Plus ...
      • Pregnancy (1)
  • Population groups (1)
  • Plus ...
    • Paediatrics (1)
Content type
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Practice guidelines (1)
Language
  • Français (1)
Active substance
  • acide clavulanique (1)
  • acide nalidixique (1)
  • amoxicilline (1)
  • ceftriaxone (1)
  • clindamycine (1)
  • doxycycline (1)
  • gentamicine (1)
  • mezlocilline (1)
  • spectinomycine (1)
  • sulbactam (1)

Practice guidelines and other guides - 1 result

  • Antenatal prevention of the risk of early neonatal bacterial infection

    Practice guidelines - Posted on 1/9/2001
    Download abstract
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
6Fqrw9SnRCaVB5FF